macrophage elastase / negative regulation of endothelial cell-matrix adhesion via fibronectin / bronchiole development / positive regulation of epithelial cell proliferation involved in wound healing / elastin catabolic process / regulation of defense response to virus by host / positive regulation of type I interferon-mediated signaling pathway / wound healing, spreading of epidermal cells / negative regulation of type I interferon-mediated signaling pathway / lung alveolus development ...macrophage elastase / negative regulation of endothelial cell-matrix adhesion via fibronectin / bronchiole development / positive regulation of epithelial cell proliferation involved in wound healing / elastin catabolic process / regulation of defense response to virus by host / positive regulation of type I interferon-mediated signaling pathway / wound healing, spreading of epidermal cells / negative regulation of type I interferon-mediated signaling pathway / lung alveolus development / response to amyloid-beta / Collagen degradation / positive regulation of interferon-alpha production / collagen catabolic process / extracellular matrix disassembly / core promoter sequence-specific DNA binding / collagen binding / Degradation of the extracellular matrix / extracellular matrix organization / extracellular matrix / metalloendopeptidase activity / cellular response to virus / protein import into nucleus / endopeptidase activity / sequence-specific DNA binding / serine-type endopeptidase activity / calcium ion binding / negative regulation of transcription by RNA polymerase II / positive regulation of transcription by RNA polymerase II / proteolysis / extracellular space / extracellular region / zinc ion binding / nucleus / cytoplasm 類似検索 - 分子機能
Text: The structure was determined using a combination of distance restraints extracted from PDSD DARR, CHHC spectra, Talos calculated angles restraints and pseudocontact shift data
-
試料調製
詳細
Solution-ID
内容
溶媒系
1
45mg/mL [U-100% 13C; U-100% 15N] ZnMMP12
notapplicable
2
45mg/mL [U-100% 13C; U-100% 15N] CoMMP12
notapplicable
3
15 + 30mg/mL [U-100% 13C; U-100% 15N] crystallized miture of 33% labelled ZnMMP-12 diluted with 67% of unlabeled CoMMP-12
notapplicable
4
15 + 30mg/mL [U-100% 13C; U-100% 15N] crystallized miture of 33% labelled CoMMP-12 diluted with 67% of unlabeled ZnMMP-12
notapplicable
試料
濃度 (mg/ml)
構成要素
Isotopic labeling
Solution-ID
45mg/mL
ZnMMP12
[U-100% 13C; U-100% 15N]
1
45mg/mL
CoMMP12
[U-100% 13C; U-100% 15N]
2
15mg/mL
crystallized miture of 33% labelled ZnMMP-12 diluted with 67% of unlabeled CoMMP-12
[U-100% 13C; U-100% 15N]
3
15mg/mL
crystallized miture of 33% labelled CoMMP-12 diluted with 67% of unlabeled ZnMMP-12
[U-100% 13C; U-100% 15N]
4
試料状態
イオン強度: low / pH: 8 / 圧: ambient / 温度: 280 K
-
NMR測定
NMRスペクトロメーター
タイプ: Bruker Avance / 製造業者: Bruker / モデル: AVANCE / 磁場強度: 700 MHz